{
  "outputs": [
    {
      "isInSupabase": "false",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "unstructuredTopicList": "1) pubmed Nerandomilast in Patients with Progressive Pulmonary Fibrosis, 2) pubmed Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis, 3) pubmed Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules, 4) pubmed Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer, 5) pubmed Effect of exercise training on modulating the TH17/TREG imbalance in individuals with severe COPD: A randomized controlled trial, 6) pubmed Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834, 7) pubmed Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial, 8) pubmed Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial, 9) pubmed Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study, 10) pubmed Beyond pulmonary rehabilitation: can the PICk UP programme fill the gap? A randomised trial in COPD, 11) pubmed A Randomized, Double-Blinded, Placebo-Controlled Study of the Use of Traditional Chinese Medicine for Treating Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease, 12) pubmed Effects of asymmetric nasal high-flow cannula on carbon dioxide in hypercapnic patients: A randomised crossover physiological pilot study, 13) pubmed Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR), 14) pubmed Physiological effects of nasal high flow therapy during exercise in patients with chronic obstructive pulmonary disease: A crossover randomised controlled trial, 15) pubmed Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment, 16) pubmed High-dose inhaled NO for the prevention of nosocomial pneumonia after cardiac surgery under cardiopulmonary bypass: A proof-of-concept prospective randomised study, 17) pubmed Nicotine in E-cigarette aerosol may lead to pulmonary inflammation, 18) pubmed Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study, 19) pubmed Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation, 20) pubmed Early effects of acetazolamide on hemoglobin mass and plasma volume in chronic mountain sickness at 5100 m, 21) pubmed Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial, 22) pubmed Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome, 23) pubmed A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancer, 24) pubmed 5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients, 25) pubmed Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot Trial, 26) pubmed Harms of Morphine for Chronic Breathlessness in Relation to Dose, Duration and Titration Phase, 27) pubmed Impact of Pulmonary Rehabilitation on Survival in People With Interstitial Lung Disease, 28) pubmed Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities, 29) pubmed Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial, 30) pubmed Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid, 31) pubmed Training-induced change of diastolic function in heart failure with preserved ejection fraction, 32) pubmed Characterizing gut microbial dysbiosis and exploring the effect of prebiotic fiber supplementation in patients with COPD, 33) pubmed The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) study, 34) pubmed A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study, 35) pubmed Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females, 36) pubmed A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO), 37) pubmed Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial, 38) pubmed Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset, 39) pubmed Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial, 40) pubmed Effectiveness and safety of Suhuang Zhike capsules in adults with asthma: A multicenter, randomized, double-blinded, placebo-controlled trial, 41) pubmed Adenotonsillectomy and Health Care Utilization in Children With Snoring and Mild Sleep Apnea: A Randomized Clinical Trial, 42) pubmed Impact of High-Density Mapping on Pulmonary Vein Isolation Durability: A Randomized, Single-Center Study, 43) pubmed Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer, 44) pubmed Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial, 45) pubmed The Adverse Effects Associated With Ibuprofen Use After Major Orthopaedic Surgeries-A Detailed Statistical Analysis Plan for the PERISAFE Randomized Clinical Trial, 46) pubmed Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment, 47) pubmed Clinical effect of pulmonary rehabilitation during radiotherapy in lung cancer: A randomized controlled trial, 48) pubmed ADRB2 genotype-guided treatment for childhood asthma: Cost analysis of the PUFFIN and PACT trials, 49) pubmed Efficacy of Atorvastatin Against Venous Thromboembolism After Total Hip Arthroplasty, 50) pubmed The Effects of Low-Dose Morphine on Sleep and Breathlessness in COPD: A Randomized Trial, 51) pubmed Effect of Power-Breath Versus Transcutaneous Electrical Diaphragmatic Stimulation on the Severity of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial, 52) pubmed Diagnostic yield and safety of transbronchial lung cryobiopsy for diffuse parenchymal lung diseases diagnosis: Comparison between 1.7-mm and 1.9-mm probes, 53) pubmed The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post-Pulmonary Embolism Syndrome, 54) pubmed Why Women Appear to Have Better Outcomes When Undergoing Screening for Lung Cancer, 55) pubmed Medical clown intervention shortens length of hospitalization in children with pneumonia, 56) pubmed A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma, 57) pubmed Preoperative inspiratory muscle training preserved diaphragmatic excursion after esophagectomy: a randomized-controlled trial, 58) pubmed The effect of singing or playing melodica on disease symptoms, self-efficacy level and exercise capacity in chronic obstructive pulmonary patients: a randomized controlled study, 59) pubmed Effects of external diaphragmatic pacing with neurally adjusted ventilatory assist on diaphragm function in AECOPD patients, 60) pubmed Nasal biomarker inflammatory profile in response to intranasal corticosteroids in pediatric obstructive sleep apnea syndrome, 61) pubmed Impact of Initial Extensive Ablation on Left Atrial Gaps During Redo Procedures and Subsequent Outcomes in Persistent Atrial Fibrillation, 62) pubmed Nonrigid temporal registration of multiphase CT pulmonary angiography using low-kV and low contrast: a feasibility study with dual-source CT, 63) pubmed Impact of Noninvasive Ventilation Before and After Cardiac Surgery for Preventing Cardiac and Pulmonary Complications: A Clinical Randomized Trial, 64) pubmed Efficacy and safety of Chinese medicine in treating risk window of AECOPD: A multicenter randomized controlled trial, 65) pubmed The effect of D-cycloserine on brain connectivity over a course of pulmonary rehabilitation - A randomised control trial with neuroimaging endpoints, 66) pubmed Development of a new ambulatory oxygen delivery method combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial, 67) pubmed Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study), 68) pubmed Clinician and Patient Responses to US Health Insurers' Policies: A Qualitative Study of Higher Risk Patients, 69) pubmed Low versus High Fraction of Inspired Oxygen During Lung Separation in Thoracic Surgery: A Randomized Controlled Trial, 70) pubmed The impact of acetazolamide and dronabinol on the physiological endotypes responsible for obstructive sleep apnea, 71) pubmed Effect of inspiratory and expiratory muscle training on respiratory function and decannulation outcome in patients with tracheostomy after stroke: a randomized controlled trial, 72) pubmed The impact of mechanical insufflation-exsufflation on the weaning success rate of tracheostomized patients on prolonged mechanical ventilation: a pilot and feasibility study of a randomized controlled trial, 73) pubmed Changes in cardiovascular disease risk, lung function and other clinical health outcomes when people who smoke use e-cigarettes to reduce cigarette smoking: an exploratory analysis from a randomised placebo-controlled trial, 74) pubmed A randomized prospective clinical study comparing wide-awake local anesthesia no tourniquet (WALANT) and spinal anesthesia in the surgical treatment of ankle fractures, 75) pubmed [Effects of acupuncture at back-shu points on respiratory function and extubation success rate in patients with post-stroke tracheotomy], 76) pubmed Post hoc analysis: 6 Months immunogenicity after third dose of BNT162b2 vs JNJ-78,436,735 after two doses of BNT162b2 vaccine in solid organ transplant recipients, 77) pubmed Could calisthenic exercises improve maximal exercise capacity, peripheral muscle strength and quality of life in dyslipidemia?, 78) pubmed Patient Centered mobile Health TECHnology Enabled Atrial Fibrillation Management (mTECH Afib): A Pilot Randomized Controlled Trial, 79) pubmed Knowledge Gain and the Impact of Stress in a Fully Immersive Virtual Reality-Based Medical Emergencies Training With Automated Feedback: Randomized Controlled Trial, 80) pubmed An App Platform-Facilitated Collaborative Palliative Care Intervention for Outpatients With Interstitial Lung Disease: A Pilot Randomized Trial, 81) pubmed Effects of Cooking with Liquefied Petroleum Gas or Biomass Fuels on Neurodevelopmental Outcomes in Preschool-Age Children Living in Puno, Peru, 82) pubmed Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial, 83) pubmed Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock, 84) pubmed Effect of muscle energy technique on pain, importance of physical activity, self-confidence, and posture in COPD patients with chronic neck pain: An experimental randomized controlled study, 85) pubmed Effect of health education intervention on treatment adherence and health status in patients with Chronic obstruction pulmonary disease: A random control trial, 86) pubmed Evaluation of a Novel eHealth Tool for Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease: Randomized Controlled Pilot and Feasibility Trial, 87) pubmed Randomised trial of home sleep apnoea testing compared to in-lab polysomnography for the evaluation of obstructive sleep apnoea in children: rationale and study protocol, 88) pubmed Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance, 89) pubmed Orthostatic-dependent cardiopulmonary responses among trained females during intensity matched resistance exercises in a pilot randomized crossover study, 90) pubmed Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self-Efficacy (CF-CSE) Scale",
      "tags": [
        "asthma",
        "copd",
        "bronchiectasis",
        "ipf",
        "sarcoidosis",
        "hp",
        "pulmonary_hypertension",
        "pe",
        "osa",
        "csa",
        "narcolepsy",
        "lung_cancer",
        "mesothelioma",
        "ards",
        "ventilation",
        "sepsis",
        "chronic_cough",
        "shortness_of_breath",
        "recurrent_pneumonia"
      ]
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Emergency Medicine",
      "unstructuredTopicList": "1. IDSA Guidelines on the Treatment and Management of Patients with COVID-19"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Emergency Medicine",
      "unstructuredTopicList": "1.2025 ACC/AHA/ACEP Acute Coronary Syndromes Guideline 2. ACEP Reaffirms EMTALA Obligations Post-Guidance Rescission 3. Physician On-Site Requirement in ED (South Carolina Law) 4. VR + Music Relieves Acute Tension Headache (RCT) 5. FDA Approves Andembry (Garadacimab) for HAE Prophylaxis 6. FDA Approves Enflonsia (Clesrovimab) for Infant RSV Prevention 7. FDA Approves Yeztugo (Lenacapavir) – 6-Month HIV PrEP Injection 8. No Benefit of Thrombectomy in Medium Vessel Stroke (ESCAPE-MeVO Trial) 9. IV Iron Falls Short in Systolic Heart Failure (FAIR-HF2) 10. BedMed Trial: BP Meds Timing Doesn't Matter 11. EAST Guideline on REBOA in Trauma 12. CDC Narrows COVID Vaccine Guidance – EM Concerns 13. Naloxone Nasal Spray Shelf-Life Extended to 4 Years 14. ACEP Clinical Policy: Carbon Monoxide Poisoning (2025) 15. Virtual Reality in Emergency Care Innovation"
    },
    {
      "isInSupabase": "true",
      "model": "4o-deep-research",
      "startDate": "2025-06-01",
      "specialty": "Emergency Medicine",
      "unstructuredTopicList": "1. A Crossover Trial of Hospital-Wide Lactated Ringer's Solution vs Normal Saline. 2. OVISS Trial: Reinforcement Learning–Guided Vasopressin Timing in Septic Shock. 3. Trials Show No Benefit of Thrombectomy for Distal and Medium Vessel Occlusions. 4. FDA Approves Enflonsia Monoclonal Antibody for RSV Prevention in Infants. 5. FDA Approves Moderna's mRNA RSV Vaccine for High-Risk Younger Adults. 6. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for Acute Coronary Syndrome Management. 7. RESCUE-3 Trial: Transvenous Diaphragm Pacing Speeds Ventilator Weaning. 8. CMS Rescinds EMTALA Guidance on Emergency Abortion Care Requirements. 9. IDSA Issues Guideline on Treating Multidrug-Resistant Pseudomonas Infections. 10. NSAIDs Recommended Over Opioids for Acute Renal Colic Pain Relief. 11. Point-of-Care Ultrasound During Cardiac Arrest Linked to Improved Outcomes. 12. HEALing Communities Trial: Community Interventions Reduce Opioid Deaths Modestly. 13. ESVS Releases 2025 Guidelines for Management of Vascular Trauma. 14. No Benefit from Long-Term Beta-Blockers Post-MI in Preserved Ejection Fraction. 15. No Added Cardiovascular Benefit to Bedtime vs Morning Antihypertensive Dosing."
    },
    {
      "isInSupabase": "true",
      "model": "o3-pro-deep-research",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "unstructuredTopicList": "2025 ACC/AHA/ACEP Guideline for Management of Acute Coronary Syndromes, 2. FLUID Trial – Lactated Ringer's vs Normal Saline, 3. FDA Approval of Merck's Enflonsia™ (Clesrovimab) for Infant RSV, 4. OPTPRESS Trial – High vs Standard MAP in Septic Shock, 5. Azithromycin vs Doxycycline for CAP in Hospital, 6. EAST Guideline on REBOA for Hemorrhagic Shock, 7. No Benefit for Thrombectomy in Distal Stroke Occlusions, 8. EAST "Trauma in Pregnancy" Guidelines, 9. Post–Cardiac Arrest Oxygen & CO₂ Targets, 10. FDA Approval of Brekiya™ (DHE Autoinjector) for Migraine/Cluster, 11. Point-of-Care High-Sensitivity Troponin RCT, 12. ASH/ISTH Updated Pediatric VTE Guidelines, 13. Normal Saline vs Lactated Ringer's in Pediatric DKA, 14. Pharmacist Intervention in ED (URGEIM Trial), 15. Inhaled Albuterol for Renal Colic Pain."
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "o3-pro-deep-research",
      "unstructuredTopicList": "1. Tarlatamab Significantly Prolongs Survival in Relapsed Small Cell Lung Cancer (DeLLphi-304 Trial) 2. Lurbinectedin Plus Atezolizumab Maintenance Improves Outcomes in Extensive-Stage SCLC (IMforte Trial) 3. Neoadjuvant Nivolumab + Chemotherapy Shows 5-Year OS Benefit in Resectable NSCLC (CheckMate 816 Update) 4. FDA Approves Taletrectinib – Next-Generation ROS1 Inhibitor for ROS1-Positive NSCLC 5. Dupilumab Approved for Children (6–11 Years) with Moderate-to-Severe Asthma as Add-On Therapy 6. As-Needed Albuterol/Budesonide (Airsupra) Cuts Severe Exacerbations ~50% in Mild Asthma (BATURA Trial) 7. New Antifibrotic Nerandomilast Slows Lung Function Decline in Progressive Pulmonary Fibrosis (FIBRONEER Trial) 8. Ganciclovir Prophylaxis in CMV+ ICU Patients Fails to Improve Outcomes and Raises Mortality (GRAIL Trial) 9. Azithromycin Provides No Benefit for Acute Wheezing in Preschool Children (AZ-SWED Study) 10. Intensive CT Surveillance of Small Pulmonary Nodules Yields No Outcome Advantage over Standard Monitoring ("Watch the Spot" Trial) 11. Tezepelumab Helps Severe Asthmatics Greatly Reduce or Eliminate Daily Oral Steroids (WAYFINDER Study) 12. Nalbuphine Extended-Release (Haduvio) Dramatically Reduces Chronic Cough in Idiopathic Pulmonary Fibrosis (Phase 2b CORAL Trial) 13. Mepolizumab (Nucala) Wins FDA Approval as First Biologic for COPD with Eosinophilic Inflammation 14. ATS 2025 Updates Guidelines on Severe Asthma: Stronger Emphasis on Biologic Selection by Endotype 15. CHEST 2025 Unveils Risk-Based Algorithm for PE Diagnosis Reducing CT Angiography Utilization Safely"
    },
    {
      "isInSupabase": "true",
      "startDate": "2025-06-01",
      "specialty": "Pulmonology",
      "model": "4o-deep-research",
      "unstructuredTopicList": "1. FDA approval of taletrectinib (Ibtrozi) for ROS1-positive advanced non–small cell lung cancer 2. FDA approval of clesrovimab (Enflonsia) monoclonal antibody to prevent RSV lower respiratory tract disease in infants entering their first RSV season 3. Phase 3 trial shows Tarlatamab (bispecific T-cell engager) significantly improves overall and progression-free survival vs chemotherapy in relapsed small cell lung cancer 4. CheckMate 816 trial confirms neoadjuvant nivolumab plus chemotherapy significantly improves overall survival in resectable NSCLC 5. Phase 3 FIBRONEER trials: oral PDE4B inhibitor Nerandomilast significantly slows forced vital capacity decline in idiopathic pulmonary fibrosis and progressive fibrosing ILD 6. New CHEST guidelines promote restrictive RBC, plasma, and platelet transfusion practices in critically ill adults, citing no mortality difference and fewer adverse events vs liberal transfusion 7. FDA approval of Mepolizumab (Nucala) as the first add-on biologic for eosinophilic COPD to reduce exacerbations and slow disease progression 8. FDA grants accelerated approval to Datopotamab Deruxtecan (TROP2-targeted ADC) for EGFR-mutated metastatic NSCLC after EGFR TKI and chemo, based on a 45% response rate in trials 9. New evidence links pulmonary rehabilitation to improved survival in ILD – 5-year mortality was 44% lower in ILD patients who completed rehab vs controls, underscoring PR as standard care in ILD 10. FDA approval of Telisotuzumab Vedotin (Emrelis), an anti-c-Met antibody–drug conjugate, for advanced MET-overexpressing NSCLC after prior systemic therapy 11. ACIP endorses Merck's RSV antibody Enflonsia (clesrovimab) for all infants <8 months old entering their first RSV season, expanding routine infant RSV prophylaxis 12. ACIP expands RSV vaccine recommendations to include adults aged 50–59 with underlying conditions, lowering the prior age threshold (60+) for RSV vaccination in high-risk U.S. adults 13. Mixed phase 3 results for IL-33 inhibitor Itepekimab in COPD – one trial showed a 27% exacerbation reduction, but a second trial failed to meet its endpoint – raise uncertainty about its approval 14. FDA approval of Yutrepia (treprostinil inhalation powder) for pulmonary arterial hypertension and PH-ILD, providing a convenient dry-powder inhaled treprostinil option for over 100,000 patients 15. NIH PrecISE adaptive trial in severe asthma reports initial findings, highlighting how biomarker-driven, precision therapies can improve outcomes for subgroups of severe, exacerbation-prone asthma"
    }
  ]
}
